Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ish K. Khanna is active.

Publication


Featured researches published by Ish K. Khanna.


Tetrahedron Letters | 1987

The mild and selective N-debenzylation of tertiary alkylamines using β-trimethylsilylethyl chloroformate.

Arthur L. Campbell; Daniel R. Pilipauskas; Ish K. Khanna; R.Allen Rhodes

Abstract Benzyl groups are efficiently and selectively cleaved from tertiary alkylamines using β-trimethylsilylethyl chloroformate. This general method is compatible with a wide range of functionality because it does not require strong hydrolytic or acidic solvolytic conditions.


Synthetic Communications | 1991

A Short and Practical Synthesis of 1-Deoxynojirimycin

James R. Behling; Payman Farid; John R. Medich; Mike G. Scaros; Michael Lee Prunier; Richard M. Weier; Ish K. Khanna

Abstract The potent glucosidase inhibitor 1-deoxynojirimycin was synthesized from L-sorbose using a short synthesis and only one protecting group. The last step, which constituted the removal of an acetonide protecting group and an intramolecular reductive amination, was accomplished on an acidic lon-exchange resin. This provided a synthesis capable of being operated on a multi-kilogram scale.


Journal of Carbohydrate Chemistry | 1995

Nucleophilic Opening of N-Carboalkoxy-2,3-anhydro-1-deoxymannojirimycin. A Useful Method for the Syntheses of 2-, 3- and 2,3-Disubstituted 1-Deoxynojirimycin Analogs

Ish K. Khanna; Francis J. Koszyk; Michael A. Stealey; Richard M. Weier; Janet Julien; Richard A. Mueller; Shashidhar N. Rao; Lydia Swenton; Daniel P. Getman; Gary A. DeCrescenzo; Robert M. Heintz

Abstract A useful methodology for the synthesis of a number of 2-, 3- and 2,3-disubstituted deoxynojirimycin analogs is reported. It has been found that the epoxides in stereoselectively synthesized N-carboalkoxy-2,3-anhydro-1-deoxymannojirimycins (4 and 5) react with N-, S- and F- nucleophiles to give a mixture of gluco and altro products. The 3-azido altro compound (12b) yields the desired gluco derivative (40) by oxidation, in situ epimerization at C-3, followed by stereoselective reduction of the carbonyl group. The azido intermediate (12a) affords the 2,3-diazido gluco compound (51) by double inversion at C-3. Attempts have been made to understand the factors contributing to the opening of epoxides (4, 5 and 9) by different nucleophiles.


Tetrahedron Letters | 1996

THE SYNTHESIS OF 1,5-DIDEOXY-1,5-(ALKYL)IMINO-2-C-METHYL-D-GLUCITOLS

Ish K. Khanna; Richard M. Weier; Janet Julien; Richard A. Mueller; David C. Lankin; Lydia Swenton

The regio- and stereoselective synthesis of the title compounds 3 and 4 has been accomplished starting with deoxynojirimycin. The factors affecting the stereochemical outcome of Grignard addition to the key carbonyl intermediate are discussed.


Tetrahedron Letters | 1993

Regiospecific addition of Grignard reagents to the 4-position of activated imidazo[4,5-c]pyridine. A convenient method for the synthesis of 4-alkyl(ary

Ish K. Khanna; Richard M. Weier

Abstract The addition of Grignard reagents to 5-acylimidazopyridinium salts gives 4-substituted 5-acyl-4,5-dihydroimidazopyridines. This reaction was utilized t


Tetrahedron Letters | 1986

Metallation of rigid 2-aryl-1,3-dioxanes

Arthur L. Campbell; Ish K. Khanna

Abstract Regioselective metallation and alkylation/acylation of 2-aryl-1,3-dioxanes was achieved in high yield.


Archive | 1993

Substituted pyrazolyl benzenesulfonamides

John J. Talley; Thomas D. Penning; Paul W. Collins; Donald J. Rogier; James W. Malecha; Julie M. Miyashiro; Stephen R. Bertenshaw; Ish K. Khanna; Matthew J. Graneto; Roland S. Rogers; Jeffery S. Carter


Archive | 1994

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

John J. Talley; Thomas D. Penning; Paul W. Collins; Donald J. Rogier; James W. Malecha; Julie M. Miyashiro; Stephen R. Bertenshaw; Ish K. Khanna; Matthew J. Graneto; Roland S. Rogers; Jeffery S. Carter; Stephen H Docter; Stella S. Yu


Archive | 1998

Prodrugs of benzenesulfonamide-containing COX-2 inhibitors

John J. Talley; James W. Malecha; Stephen R. Bertenshaw; Matthew J. Graneto; Jeffery S. Carter; Jinglin Li; Srinivasan Nagarajan; David L. Brown; Donald J. Rogier; Thomas D. Penning; Ish K. Khanna; Xiangdong Xu; Richard M. Weier


Archive | 1999

Substituted pyrazoles as p38 kinase inhibitors

Ashok S. Naraian; Michael Clare; Paul W. Collins; Joyce Zuowu Crich; Rajesh Ballwin Devraj; Daniel L. Flynn; Lifeng Geng; Matthew J. Graneto; Cathleen E Hanau; Gunnar J. Hanson; Susan J. Hartmann; Michael St. Charles Hepperle; He Huang; Francis J. Koszyk; Shuyuan Liao; Suzanne Metz; Richard A. Partis; Thao D. Red Bud Perry; Shashidhar N. Rao; Shaun Raj Selness; Michael S. South; Michael A. Stealey; John J. Talley; Michael L. Vazquez; Richard M. Weier; Xiangdong Xi; Ish K. Khanna; Yi Yu

Collaboration


Dive into the Ish K. Khanna's collaboration.

Researchain Logo
Decentralizing Knowledge